To determine the accuracy of the Syva (Palo Alto, Calif.) direct fluorescent-antibody (DFA) test in comparison with the Gen-Probe (San Diego, Calif.) Accuprobe culture confirmation test, we tested 395 isolates of Neisseria gonorrhoeae from cultures obtained from patients attending a sexually transmitted disease clinic from 1 July 1991 through 30 June 1992. All isolates were tested for DFA reactivity with a polyclonal reagent (Difco Laboratories, Detroit, Mich.) and a monoclonal reagent (Syva, Inc., direct specimen test) and for specific molecular probe reactivity by the Gen-Probe Accuprobe culture confirmation test for N. gonorrhoeae. The 395 isolates gave positive results for the Gen-Probe culture confirmation test and the Difco polyclonal direct specimen test. However, 18 (4.6%) of the isolates were negative for N. gonorrhoeae by the Syva DFA test. With the exception of six 13-lactamase-positive isolates, all isolates that were negative by Syva DFA were sensitive to penicillin, tetracycline, spectinomycin, and ceftriaxone by disk-diffusion susceptibility testing. Auxotyping and serotyping studies indicated that strains negative by Syva DFA consisted of several variants. The frequency of N. gonorrhoeae isolates showing negative results by Syva DFA in this patient population ranged from 0 to 11.5%'Y/month. Laboratories using only the Syva DFA test for confirmation of N. gonorrhoeae may incur a significant risk of misidentification.
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Rapid identification of Neisseria gonorrhoeae has been improved by the introduction of direct fluorescent-antibody (DFA) testing of presumptive N. gonorrhoeae isolates in place of the conventional sugar utilization method. However, polyclonal DFA reagents for N. gonorrhoeae are recognized to produce false-positive results for other Neisseria spp. (1, 4) and false-negative results for N. gonorrhoeae isolates (11, 14) . In addition, Waitkins and Anderson (15) described penicillinase-producing N. gonorrhoeae (PPNG) isolates with negative DFA reaction by a commercial polyclonal conjugate. The introduction of monoclonal reagents was followed by reports of significant improvement in the specificity of the DFA test (6, 17) . Although the monoclonal Syva DFA test (Syva, Inc., Palo Alto, Calif.) was initially reported as 100% sensitive, a subsequent report by Walton (16) (7) . The detection version of this DNA probe test has been reported as highly sensitive as well (2, 8, 10) .
A total of 11 (61.1%) of the 18 Syva DFA-negative isolates were recovered from predominantly young black males (average age, 25.3 years). All were urethral isolates. The remaining seven (38.9%) isolates were recovered from females (four blacks, two Hispanics, and one white). Three isolates were recovered from cervical swabs; two were recovered from rectal specimens. Five (27.8%) of the isolates were P-lactamase positive and were recovered from three men and two women. Resistance was not detected for any other antibiotic tested (tetracycline, spectinomycin, and ceftriaxone). All 10 isolates recovered from patients in the July to December 1991 period were prototrophic-nontypeable (proto-NT) in auxotype-serovar (A-S) profile although two of these isolates were PPNG. Subsequently, two other A-S profiles, P-arginine-IB-20 and proto-IB-24, were recovered from patients whose specimens were cultured during the January-to-June 1992 period. The transient appearance of isolates negative by Syva DFA was similar to that described for many A-S types (12 (6, 17) . Subsequent case reports of DFA-negative strains gave no indication of the incidence of these strains (16) . We found that a significant percentage (4.6%) of N. gonorrhoeae isolates recovered from sexually transmitted disease clinic patients yielded a negative reaction by the Syva DFA test while exhibiting appropriate reactions with conventional biochemicals, a polyclonal DFA test (Difco), and the Gen-Probe N. gonorroeae CC test. Since the target epitope for the Syva monoclonal antibody conjugate resides on the principal outer membrane protein, it was assumed that a genetic variant or variants were circulating in the affected population. The A-S data indicate that multiple variants were recovered from clinic patients. The most commonly recovered variant, proto-NT, did not react with the commercial monoclonal reagent or the standard panel of typing reagents employed by the Centers for Disease Control and Prevention for this determination.
To our knowledge, this is the first report of the incidence of Syva DFA-negative isolates. The incidence of these isolates in other regions may be less or greater than that observed in our study. Laboratories considering use of the Syva DFA test as the sole means for confirmation of N. gonorrhoeae may incur a significant risk of misidentification and may wish to determine the frequency of N. gonorrhoeae isolates which are negative by the Syva DFA test before beginning routine use. We recommend that laboratories which are already using the Syva DFA test for confirmation refer isolates with colonial and microscopic morphology typical of N. gonorrhoeae but negative results by the Syva DFA test to another laboratory which uses sugar fermentation or a molecular probe method for confirmation.
No false-negative results were obtained for the Gen-Probe CC test during this study. The use of highly conserved nucleotide sequences as a target for a DNA probe confirmation test may be superior to the use of principal outer membrane protein epitopes as a target for specific monoclonal antibodies for routine laboratory confirmation of N. gonorrhoeae.
